Federico Caldart

ORCID: 0000-0002-2798-552X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatitis Pathology and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Eosinophilic Esophagitis
  • COVID-19 Clinical Research Studies
  • IgG4-Related and Inflammatory Diseases
  • SARS-CoV-2 detection and testing
  • Gastroesophageal reflux and treatments
  • Gastrointestinal disorders and treatments
  • Neuroendocrine Tumor Research Advances
  • Liver Disease Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Gastrointestinal motility and disorders
  • Eosinophilic Disorders and Syndromes
  • Diet, Metabolism, and Disease
  • Nutrition and Health in Aging
  • COVID-19 epidemiological studies
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Microscopic Colitis
  • Congenital gastrointestinal and neural anomalies
  • Advanced Graph Neural Networks
  • Bariatric Surgery and Outcomes
  • Esophageal and GI Pathology
  • IL-33, ST2, and ILC Pathways
  • Phagocytosis and Immune Regulation
  • COVID-19 Digital Contact Tracing

University of Verona
2021-2025

University of Padua
2020-2022

10.1038/s41586-020-2488-1 article EN other-oa Nature 2020-06-30

Abstract Objectives Type 2 is a rare form of autoimmune pancreatitis (AIP). Despite being considered benign disease, only few studies with limited sample size and short follow‐up have been published on type AIP. The aim this observational study was to evaluate long‐term outcomes, such as the risk relapse, pancreatic insufficiency cancer in large AIP cohort long follow‐up. Methods Patients definitive or probable diagnosis by International Consensus Diagnostic Criteria (ICDC) present our...

10.1002/ueg2.12504 article EN cc-by-nc-nd United European Gastroenterology Journal 2024-01-12

In February and March 2020, two mass swab testing campaigns were conducted in Vo', Italy. May we tested 86% of the Vo' population with three immuno-assays detecting antibodies against spike nucleocapsid antigens, a neutralisation assay Polymerase Chain Reaction (PCR). Subjects positive to PCR February/March or serological again November. Here report on results analysis November surveys. We estimate seroprevalence 3.5% (95% Credible Interval (CrI): 2.8-4.3%) May. November, 98.8% Confidence...

10.1038/s41467-021-24622-7 article EN cc-by Nature Communications 2021-07-19

The continuous emergence of SARS-CoV-2 variants concern (VOC) with immune escape properties, such as Delta (B.1.617.2) and Omicron (B.1.1.529), questions the extent antibody-mediated protection against virus. Here we investigated long-term antibody persistence in previously infected subjects B.1, B.1.617.2 BA.1 unvaccinated infected, vaccinated naïve subjects.

10.1186/s13073-022-01066-2 article EN cc-by Genome Medicine 2022-06-10

Summary Background Data on the role of microbiome in adult patients with eosinophilic oesophagitis (EoE) are limited. Aims To prospectively collect and characterise salivary, oesophageal gastric EoE, further correlating findings disease activity. Methods Adult symptoms dysfunction undergoing upper endoscopy were consecutively enrolled. Patients classified as EoE patients, case more than 15 eosinophils per high‐power field, or non‐EoE controls, lack infiltration. Before during endoscopy,...

10.1111/apt.17091 article EN cc-by-nc Alimentary Pharmacology & Therapeutics 2022-06-17

Autoimmune pancreatitis (AIP) is a steroid-responsive inflammatory disease of the pancreas. Few studies investigated pancreatic exocrine function (PEF) in patients suffering from AIP and no definitive data are available on effect steroids PEF recovery. Aim study evaluation severe insufficiency (sPEI) prevalence at clinical onset after steroid treatment.

10.1016/j.pan.2024.04.006 article EN cc-by Pancreatology 2024-04-24

Chronic pancreatitis is a common inflammatory disease that severely impairs patients' quality of life, mainly due to abdominal pain which the most frequent symptom. Current guidelines suggest medical therapy as first line intervention based on stepwise use analgesics (i.e. NSAIDs followed by weak opioids and later strong oppioids), rarely effective in improving often leads opioid addiction. Interventional procedures are therefore frequently needed. Endoscopic suggested second intervention,...

10.1080/17474124.2024.2321947 article EN Expert Review of Gastroenterology & Hepatology 2024-02-20

Graph Neural Networks (GNNs) are nowadays widely used in many real-world applications.Nonetheless, the data relationships can be a source of biases based on sensitive attributes (e.g., gender or ethnicity).Several methods have been proposed to learn fair graph node representations.In this work we extend NIFTY, an approach that exploits additional terms loss function perturbing input enforce fairness GNNs.In particular, exploit biased perturbation adjacency matrix able reduce edge...

10.14428/esann/2022.es2022-99 article EN ESANN 2021 proceedings 2022-01-01

Background: In February and Mach 2020, two mass swab testing campaigns conducted in Vo', Italy demonstrated the extent of asymptomatic SARS-CoV-2 infection feasibility epidemic suppression.Methods: We tested 86% Vo' population (2,602 subjects) May with three immuno-assays detecting antibodies against spike (S) nucleocapsid (N) antigens, a neutralisation assay Polymerase Chain Reaction (PCR). Subjects positive to PCR February/March or serological were again November.Findings: Combining...

10.2139/ssrn.3792892 article EN SSRN Electronic Journal 2021-01-01

Abstract In February and March 2020, one of the first Italian clusters SARS-CoV-2 infection was detected in municipality Vo’. Positive subjects were followed up at 2 9 months post-infection with different immuno-assays a micro-neutralisation test. Here we report on results third serosurvey conducted same population June 2021, 15 post-infection, when tested 61% infected individuals (n=76). Antibodies against spike (S) antigen significantly decreased (P<0.006, Kruskal-Wallis test) among...

10.21203/rs.3.rs-1131280/v1 preprint EN cc-by Research Square (Research Square) 2021-12-08
Coming Soon ...